Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - FREE CASH FLOW
Free Cash Flow NBIX - Neurocrine Biosciences, Inc.
557 M
LAST VALUE
31.36%
2 YEAR CAGR
32.33%
5 YEAR CAGR
29.66%
10 YEAR CAGR